Michael Levin at Tufts: The Bioelectric Code

If Fritz-Albert Popp gave us the photonic channel of the cell, Michael Levin gives us the electric one. For two decades his lab at Tufts University has been quietly rewriting the textbook on how biology decides what to build. Voltage gradients across cell membranes are not just metabolic by-products. They are a control variable — and a programmable one.

From frog embryology to bioelectric signaling

Levin trained in computer science before biology and never quite left the engineering mindset behind. After a PhD in genetics at Harvard, he moved into developmental biology, originally studying left-right asymmetry in vertebrate embryos — why your heart is on the left and your liver on the right. What he found unsettled him: the asymmetry was already encoded electrically at the cleavage stage, before any of the classical genetic regulators were active.^[1]

That observation became the thesis of his career: biology runs an electrical layer that's older, deeper, and more decisive than the genetic one. He founded the Allen Discovery Center for Reading and Writing the Morphogenetic Code at Tufts in 2018 with backing from the Paul G. Allen Family Foundation, and the lab has since produced one paradigm-shifting result after another.

The bioelectric code

Every cell maintains a voltage across its membrane — typically around -70 millivolts, sustained by ion pumps and selective channels. Levin's framework, the bioelectric code, says these voltages don't just exist passively at the single-cell level. They form tissue-scale patterns — coherent voltage maps across an entire organ or body axis — and those patterns are read by cells to determine what to build.^[2]

You can read the voltage map directly using voltage-sensitive fluorescent dyes. The Levin lab has imaged the map across early embryos and shown that the pattern preexists the structure. A frog embryo "shows" its future face — eyes, mouth, jaw lines — as a voltage pattern before any of those tissues form physically. They named one such image the electric face.

The measured properties

Across hundreds of peer-reviewed experiments, Levin's lab and collaborators have demonstrated:

• Voltage patterns are causally upstream of structure. Change the voltage map and the structure follows.
• They are programmable. Specific ion-channel openers and blockers can rewrite them in ways that produce predictable anatomical outcomes.
• They are scale-invariant. The same voltage logic operates from single cells to whole-body axes.
• They are partially independent of the genome. Same genome, different voltage map, different anatomy.

The planaria findings

The clearest demonstration uses planaria — flatworms that can regenerate from almost any fragment. Cut a planarian in half across the middle, and the head end regrows a tail, the tail end regrows a head. The classical view: chemical gradients tell each end what to make.

Levin's lab showed something different. By briefly bathing the cut worm in a drug that blocks a specific potassium channel (1-octanol, or various gap-junction modulators), they could produce two-headed worms — the tail end, instead of growing a tail, grows a second head.^[3]

More remarkable: the two-headed phenotype is stable across generations of regeneration. Cut the two-headed worm in half again, with no further drug exposure, and you get two two-headed worms. The voltage pattern has become the new memory of "what to build" — the genome is unchanged, but the bioelectric layer has been rewritten and persists.

This is one of the cleanest demonstrations in modern biology that information lives somewhere other than DNA.

Eyes in unusual places

In 2011, the Levin lab showed they could induce a complete, functional eye to form on a tadpole's flank, gut, or tail — anywhere on the body, far from where eyes "belong" — simply by manipulating local voltage with ion-channel modulators.^[4] The induced eyes had retinas, lenses, optic nerves; they connected to the central nervous system in unexpected places and the animal could process visual information through them.

The genetic instructions for "eye" were always present in every cell. What was missing was the voltage pattern that says: build it here. Restore the pattern, and the cells follow.

Tumor reversion by voltage normalization

If voltage patterns control morphogenesis, they should also be relevant to misfiring morphogenesis — cancer. Several Levin-lab and collaborator papers have shown that tumors in frog and mammalian models display aberrant voltage signatures, and that pharmacologically normalizing the voltage causes tumor cells to revert to normal morphology and behavior.^[5]

The mechanism is not killing the cancer cells. It is convincing them to behave again. Membrane voltage modulation reactivates the morphogenetic field they had drifted out of. We are very careful here: this is in vitro and animal-model work, and Tesla BioLights makes no clinical claims about cancer. We are pointing at the upstream principle. Voltage is a control variable. The literature is published in Cell Cycle, Disease Models & Mechanisms, and Oncotarget.

Xenobots: synthetic life made from frog cells

In 2020, Levin and collaborator Josh Bongard (UVM) introduced xenobots — millimeter-scale "living machines" assembled from frog skin and heart cells, designed in silico by an evolutionary algorithm and built by hand.^[6] Xenobots swim, push pellets, work in groups, and even self-replicate kinematically — gathering loose cells and assembling new xenobots from them.

What makes this relevant to the bioelectric code: xenobots demonstrate that the same cells, given a different morphogenetic instruction, build a completely different organism. The frog genome is intact. There's no genetic engineering. What changed is the bioelectric and contextual signaling. The cells became "agents" in a new body plan.

If you needed a single experimental result to support the claim that biology is plastic at the level of electrical-pattern instructions, the xenobots are it.

The Cognitive Light Cone

Levin's recent theoretical work, often co-developed with philosophers like Daniel Dennett, frames cells (and tissues, and organs) as basal cognitive agents. Each level of biological organization has a cognitive light cone — a horizon of states it can perceive and goals it can pursue, scaled to its substrate.

A single cell's cognitive light cone is small (sense local chemistry, regulate transport). A tissue's is larger (build a structure, repair damage). A human brain's is vast (model the universe). But the framework is continuous: bioelectric signaling is the medium through which lower-level agents are recruited into higher-level goals. Tear that signaling, and the higher-level goal (a healthy body) fragments into a lower-level one (just survive, just grow, just consume) — which is one way to describe what cancer is.

This view places bioelectricity at the foundation of biological information processing, not just biological housekeeping.

"What we found is that biology runs on an information layer that is at least as old as the genome, and arguably much older. Cells were doing bioelectric computation a billion years before they invented neurons. Once you see this, you can never go back to thinking of the cell as just a chemical machine."
— Michael Levin, Allen Discovery Center lecture, 2023

Where the field stands now

Bioelectric signaling has moved from fringe to mainstream developmental biology in the past decade. Levin's lab has trained dozens of researchers now leading their own programs. Cell, Science, PNAS, and Nature publish bioelectric work routinely. Major pharma is exploring voltage-modulating compounds for regenerative-medicine indications. Bioelectric medicine is becoming a recognized clinical category, with FDA-cleared neural stimulators leading the way.

The phenomenon is documented. The mechanism is mapped at the level of ion channels and voltage patterns. What's still open is the engineering question: how to apply external fields safely and precisely to nudge endogenous bioelectric patterns in therapeutic directions. That's exactly the question Tesla BioLights operates within.

What Levin means for Tesla BioLights

Read alongside yesterday's profile of Popp, the case becomes clearer:

1. Cells communicate via bioelectric voltage patterns. (Levin, two decades of peer-reviewed work.)
2. Cells communicate via biophotonic emission. (Popp, four decades of peer-reviewed work.)
3. External electromagnetic and photonic fields measurably interact with both channels. (PEMF clinical literature; photobiomodulation clinical literature; FDA-cleared since 1979.)
4. A device that emits broad-spectrum photonic light and a pulsed electromagnetic field is, in principle, addressing both information channels simultaneously.

That is not metaphor. It is the engineering thesis of the S.E.A.D. System. Levin's research is what makes the electric half of that thesis scientifically defensible.

Where Levin's framework reaches in this Journal

The bioelectric channel established here threads forward through the rest of the Journal. Day 12 (Mitochondria as Light Antennae) covers the metabolic channel that runs alongside the bioelectric one. Day 13 (the 600–1100 nm optical window) gives the dosimetry of how the photonic signal reaches the tissue. Day 14 (the inert pharmacology of noble gases) connects the voltage-gated ion channels Levin studies to the TREK-1 and NMDA receptor pharmacology of xenon and argon. Day 15 (the vagal path) ties the cell-level bioelectric story to the body-level parasympathetic state. Day 16 (the quantum floor of biology) shows that the ion channels and voltage gradients Levin investigates rest on a substrate of quantum-mechanical events at femtosecond timescales.

Tomorrow on the Journal

Day 12: Mitochondria as Light Antennae. The molecular machinery inside every cell that absorbs red and near-infrared photons and converts them into ATP. The FDA-cleared chromophore underneath every photobiomodulation device on the market. The bridge between Popp's biophotonics and the cytochrome c oxidase pathway that hundreds of clinical trials have characterized in detail.

For the full peer-reviewed scientific deep-dive across all twelve domains, see the Science Report. For the 130-year lineage from Tesla through Lakhovsky, Priore, Rife, Popp, and Levin, see our lineage page. For Day 4's earlier introduction to the bioelectric code in a different frame, see that essay.